Alcon Inc
Research Alcon Inc (ALC) on Bullrun: valuation model: 17.8% overvalued, market cap USD 35.47B, P/E 56.3, dividend yield 0.5%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerALC
- ExchangeNYSE
- CountrySwitzerland
- SectorHealthcare
- IndustryMedical Instruments & Supplies
- CurrencyUSD
- Valuation signal17.8% overvalued
- Market capUSD 35.47B
- P/E56.3
- Dividend yield0.5%
- Financial periodQ1 2026
- RevenueUSD 2.71B
- Net incomeUSD 189.00M
- Free cash flowUSD 1.59B
- Gross margin56.4%
Valuation Snapshot
Bullrun's latest valuation model marks Alcon Inc as 17.8% overvalued; latest market cap is USD 35.47B; P/E is 56.3; dividend yield is 0.5%.
Peer valuation comparison
Latest P/E is 56.26x versus a Healthcare sector median of 24.46x (130.0% above).
Latest dividend yield is 0.5% versus a Healthcare sector median of 2.11% (76.3% below).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 10.40B | USD 980.00M | USD 1.61B | 55.2% | 1.97 | USD 1.50B | USD 509.00M | USD 22.01B |
| FY2024 | USD 9.91B | USD 1.02B | USD 1.41B | 55.6% | 2.05 | USD 1.68B | USD 497.00M | USD 21.53B |
| FY2023 | n/a | n/a | n/a | n/a | 3.06 | USD 1.09B | USD 5.14B | USD 20.62B |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-25 | USD 35.47B | 56.3 | 0.5% | 0.36 |
| 2025 | 2025-12-31 | USD 38.41B | 40.0 | n/a | n/a |
| 2024 | 2024-12-31 | USD 41.99B | 41.4 | 0.3% | 0.26 |
| 2023 | 2023-12-29 | USD 38.42B | 85.8 | 0.3% | 0.24 |
| 2022 | 2022-12-30 | USD 33.71B | 59.1 | 0.3% | 0.21 |
| 2021 | 2021-12-31 | USD 42.70B | 114.6 | 0.1% | 0.11 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0.36 USD, yield 0.5%.
About Alcon Inc
Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products worldwide. The company operates through two segments, Surgical and Vision Care. It offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for surgical procedures.
Related stock research
Other Healthcare stocks
Frequently asked questions
Is Alcon Inc overvalued or undervalued?
Bullrun's valuation model currently marks Alcon Inc as 17.8% overvalued.
What is Alcon Inc's market cap?
Alcon Inc's market capitalization is USD 35.47B.
What is Alcon Inc's P/E ratio?
Alcon Inc's price-to-earnings (P/E) ratio is 56.3.
Does Alcon Inc pay a dividend?
Alcon Inc has a dividend yield of 0.5%.
What does Alcon Inc do?
Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products worldwide. The company operates through two segments, Surgical and Vision Care. It offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for surgical procedures.